《血癌发现》(Blood Cancer Discovery)是一本以Multiple综合研究为特色的国际期刊。该刊由NLM (Medline)出版商该刊已被国际重要权威数据库SCIE收录。期刊聚焦Multiple领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为该领域同行进行快速学术交流的信息窗口与平台。该刊2023年影响因子为11.5。CiteScore...
《Blood Cancer Discovery》国际简称:BLOOD CANCER DISCOV,是由出版商NLM (Medline)出版的一本致力于发布--研究新成果的的专业学术期刊。主要发表刊登有创见的学术论文文章、行业最新科研成果,扼要报道阶段性研究成果和重要研究工作的最新进展,选载对学科发展起指导作用
This journal has been indexed by ESCI and is planned to be indexed by SCIE, with an expected high impact factor. 《血癌发现》是由美国癌症研究学会(AACR)出版的国际同行评审期刊,专注于血液系统疾病的基础、转化和临床研究。该期刊旨在发表在血液病领域具有重大发现及较大影响力的研究内容,推动血液病研究...
期刊名称:《Blood cancer discovery.》|2020年第1期 关键词: fusion proteins; Transcription Factors; motivationPrecursor B-Cell Lymphoblastic Leukemia-LymphomaLipid MetabolismDRIVESfusion (melting)Chromatin Immunoprecipitationmyocyte enhancer factor 2D; 11.The Chromosome 13 Conundrum in Multiple Myeloma ...
Although there are still technical issues such as significant noise and low sequencing depth to be addressed, these techniques have greatly influenced medical discovery. It is highly important that the technologies, tools and practical single-cell applications in cancer study are enhanced and further ...
Blood Cancer Journal Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field. ...
While some of the genes harboring germline variants with a significant burden in myeloid malignancy cases had previously been implicated in blood cancer predisposition, such as CHEK2,24 several were unknown. Among this group, CTR9 was of particular interest because germline variants in the gene had...
Early diagnosis of head and neck cancer can improve therapeutic outcomes but remains a challenge. The blood proteome can comprise a key source of biomarker
Myelofibrosis (MF) is a myeloproliferative neoplasm characterized by ineffective clonal hematopoiesis, splenomegaly, bone marrow fibrosis, and the propensity for transformation to acute myeloid leukemia. The discovery of mutations in JAK2, CALR, and MPL
there are only a few studies on serum metabolomics focused on BC biomarker discovery. So far, most studies related to the analysis of serum of patients with bladder cancer have been carried out using NMR12,13,14or mass spectrometry coupled with liquid7,15,16,17,18,19and gas chromatography ...